EUS and related technologies for the diagnosis and treatment of pancreatic disease: research gaps and opportunities-Summary of a National Institute of Diabetes and Digestive and Kidney Diseases workshop.

Linda S Lee, Dana K Andersen, Reiko Ashida, William R Brugge, Mimi I Canto, Kenneth J Chang, Suresh T Chari, John DeWitt, Joo Ha Hwang, Mouen A Khashab, Kang Kim, Michael J Levy, Kevin McGrath, Walter G Park, Aatur Singhi, Tyler Stevens, Christopher C Thompson, Mark D Topazian, Michael B Wallace, Sachin Wani, Irving Waxman, Dhiraj Yadav, Vikesh K Singh

Journal: Gastrointestinal endoscopy 2018;86(5):768-778

PMID: 28941651

Free Full Text on PubMed Central View on PubMed

Abstract

A workshop was sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases to address the research gaps and opportunities in pancreatic EUS. The event occurred on July 26, 2017 in 4 sessions: (1) benign pancreatic diseases, (2) high-risk pancreatic diseases, (3) diagnostic and therapeutics, and (4) new technologies. The current state of knowledge was reviewed, with identification of numerous gaps in knowledge and research needs. Common themes included the need for large multicenter consortia of various pancreatic diseases to facilitate meaningful research of these entities; to standardize EUS features of different pancreatic disorders, the technique of sampling pancreatic lesions, and the performance of various therapeutic EUS procedures; and to identify high-risk disease early at the cellular level before macroscopic disease develops. The need for specialized tools and accessories to enable the safe and effective performance of therapeutic EUS procedures also was discussed.

Address: Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.; Departments of Cancer Survey and Gastrointestinal Oncology, Osaka Prefectural Hospital Organization, Osaka International Cancer Institute, Osaka, Japan.; Department of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Division of Gastroenterology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Comprehensive Digestive Disease Center, Department of Gastroenterology and Hepatology, University of California at Irvine Health, Orange, California, USA.; Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.; Division of Gastroenterology, Indiana University Health Medical Center, Indianapolis, Indiana, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA.; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Division of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.; Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.; Department of Pathology, University of Pittsburgh Medical Center, Sewickley, Pennsylvania, USA.; Department of Gastroenterology, Cleveland Clinic, Cleveland, Ohio, USA.; Department of Gastroenterology and Hepatology, Mayo Clinic Florida, Jacksonville, Florida, USA.; Division of Gastroenterology and Hepatology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Department of Medicine, The University of Chicago Comprehensive Cancer Center, University of Chicago School of Medicine, Chicago, Illinois, USA.

DOI: 10.1016/j.gie.2017.08.006